药物与临床

星状神经节阻滞联合右美托咪定经鼻喷雾治疗对失眠患者的疗效

  • 黄梓琪 ,
  • 范晓敏 ,
  • 刘芳 ,
  • 林宝佳 ,
  • 胡顺晴 ,
  • 刘湘钰 ,
  • 王双瑞 ,
  • 王勇佳 ,
  • 张新建
展开
  • 1.广州中医药大学第三临床医学院 (广东 广州 510405 )
    2.广州中医药大学第三附属医院麻醉科 (广东 广州 510378 )

收稿日期: 2024-11-08

  网络出版日期: 2025-02-19

基金资助

广东省医学科学技术研究基金项目(A2024696);广东省颐养健康慈善基金会资助项目(2024038)

Clinical efficacy of stellate ganglion block combined with intranasal dexmedetomidine spray in patients with insomnia disorders

  • Ziqi HUANG ,
  • Xiaomin FAN ,
  • Fang LIU ,
  • Baojia LIN ,
  • Shunqing HU ,
  • Xiangyu LIU ,
  • Shuangrui WANG ,
  • Yongjia WANG ,
  • Xinjian. ZHANG
Expand
  • *.The Third Clinical Medical College of Guangzhou University of Chinese Medicine,Guangzhou 510405,Guangdong,China

Received date: 2024-11-08

  Online published: 2025-02-19

摘要

目的 评价星状神经节阻滞(SGB)联合右美托咪定经鼻喷雾治疗对失眠患者的疗效。 方法 选取18 ~ 75岁失眠患者64例,随机分为实验组(DS组)和对照组(S组),S组连续14 d进行SGB术,DS组在此基础上于第1 ~ 6天睡前30 min经鼻喷雾给予100 μg右美托咪定,观察并记录两组患者治疗前(T1)、治疗后次日(T2)以及治疗后1个月(T3)匹兹堡睡眠质量指数(PSQI)、抑郁自评量表(SAS)、焦虑自评量表(SDS)评分和心理运动警觉性测试(PVT)结果。 结果 组内比较:DS组和S组在T2和T3时的PSQI评分与各维度分值显著低于T1时(P < 0.05)。DS组和S组的SAS和SDS评分在T3时与T1、T2时相比显著降低(P < 0.05),而PVT结果无显著变化(P > 0.05)。组间比较:DS组在T2(8.44 ± 2.99)和T3(8.22 ± 2.60)时的PSQI评分与各维度分值均显著低于S组在T2(10.88 ± 2.56)和T3(10.88 ± 2.84)时的PSQI评分与各维度分值(P < 0.05),DS组和S组的SDS和SAS评分在T2、T3时相比无显著变化(P > 0.05)。 结论 星状神经节阻滞联合右美托咪定经鼻喷雾治疗与单独SGB术相比,能够显著改善失眠患者的睡眠质量,而对其焦虑抑郁情绪及精神警觉性的影响无明显差异。

本文引用格式

黄梓琪 , 范晓敏 , 刘芳 , 林宝佳 , 胡顺晴 , 刘湘钰 , 王双瑞 , 王勇佳 , 张新建 . 星状神经节阻滞联合右美托咪定经鼻喷雾治疗对失眠患者的疗效[J]. 实用医学杂志, 2025 , 41(3) : 391 -395 . DOI: 10.3969/j.issn.1006-5725.2025.03.013

Abstract

Objective To evaluate the clinical efficacy of stellate ganglion block (SGB) combined with intranasal dexmedetomidine for the treatment of insomnia. Methods A total of 64 patients aged 18 to 75 with insomnia were randomly assigned to either the experimental group (DS group) or the control group (S group). The S group received SGB treatment for 14 consecutive days, whereas the DS group received an additional intranasal dexmedetomidine spray at a dose of 100 μg, administered 30 minutes before bedtime on days 1 through 6, in conjunction with SGB. We measured and recorded the Pittsburgh Sleep Quality Index (PSQI), Self?Rating Depression Scale (SDS), Self?Rating Anxiety Scale (SAS) scores, and Psychomotor Vigilance Test (PVT) results for both groups at three time points: baseline (T1), the day after treatment (T2), and one month after treatment (T3). Results Intra?group Comparison: In both the DS and S groups, PSQI scores and dimensionspecific scores at T2 and T3 were significantly lower compared to T1P < 0.05). SAS and SDS scores in both groups showed a significant reduction at T3 compared to T1 and T2P < 0.05), while PVT results exhibited no significant changes(P > 0.05). Inter?group Comparison: The PSQI scores and dimensionspecific scores in the DS group at T2 (8.44 ± 2.99) and T3 (8.22 ± 2.60) were significantly lower than those in the S group at T2 (10.88 ± 2.56) and T3(10.88 ± 2.84) (P < 0.05). However, no significant differences were observed in SDS and SAS scores between the DS and S groups at T2 and T3P > 0.05). Conclusion Compared to standalone SGB, the combination of SGB with intranasal dexmedetomidine significantly enhances sleep quality in patients with insomnia, while not impacting their levels of anxiety, depression, or alertness.

参考文献

1 王威, 陈勇, 熊利泽, 等. 麻醉科医师在睡眠医学中的作为[J]. 临床麻醉学杂志, 2023,39(3): 294-298.
2 STREATFEILD J, SMITH J, MANSFIELD D, et al. The social and economic cost of sleep disorders[J]. Sleep, 2021,44(11):zsab132. doi:10.1093/sleep/zsab132
3 SACMACI H, TANIK N, INAN L E. Current perspectives on the impact of chronic migraine on sleep quality: A literature review[J]. Nat Sci Sleep, 2022,14: 1783-1800. doi:10.2147/nss.s335949
4 SHAHA D P. Insomnia management: A review and update[J]. J Fam Pract, 2023,72(6 ): S31-S36. doi:10.12788/jfp.0620
5 MORIN C M, JARRIN D C. Epidemiology of insomnia: Prevalence, course, risk factors, and public health burden[J]. Sleep Med Clin, 2022,17(2): 173-191. doi:10.1016/j.jsmc.2022.03.003
6 SYS J, VAN CLEYNENBREUGEL S, DESCHODT M, et al. Efficacy and safety of non-benzodiazepine and non-z-drug hypnotic medication for insomnia in older people: A systematic literature review[J]. Eur J Clin Pharmacol, 2020,76(3): 363-381. doi:10.1007/s00228-019-02812-z
7 COHEN Z L, EIGENBERGER P M, SHARKEY K M, et al. Insomnia and other sleep disorders in older adults[J]. Psychiatr Clin North Am, 2022,45(4): 717-734. doi:10.1016/j.psc.2022.07.002
8 顾宇, 岳馨, 韩翃, 等. 超声引导下星状神经节阻滞治疗老年失眠症的效果[J]. 中国老年学杂志, 2024,44(3): 594-597.
9 DAI D, ZHENG B, YU Z, et al. Right stellate ganglion block improves learning and memory dysfunction and hippocampal injury in rats with sleep deprivation[J]. BMC Anesthesiol, 2021,21(1): 272. doi:10.1186/s12871-021-01486-4
10 YAN S, WANG Y, YU L, et al. Stellate ganglion block alleviates postoperative sleep disturbance in patients undergoing radical surgery for gastrointestinal malignancies[J]. J Clin Sleep Med, 2023,19(9): 1633-1642. doi:10.5664/jcsm.10632
11 PURDON P L, SAMPSON A, PAVONE K J, et al. Clinical electroencephalography for anesthesiologists: PartⅠ: Background and basic signatures[J]. Anesthesiology, 2015,123(4): 937-960. doi:10.1097/aln.0000000000000841
12 NELSON L E, LU J, GUO T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J]. Anesthesiology, 2003,98(2): 428-436. doi:10.1097/00000542-200302000-00024
13 GE L, GUYATT G, TIAN J, et al. Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies[J]. Sleep Med Rev, 2019,48: 101215. doi:10.1016/j.smrv.2019.101215
14 RIEMANN D, BENZ F, DRESSLE R J, et al. Insomnia disorder: State of the science and challenges for the future[J]. J Sleep Res, 2022,31(4): e13604. doi:10.1111/jsr.13604
15 宋立敏, 鲁珊珊, 王大伟, 等. 慢性失眠患者睡眠结构与注意力、记忆的相关性[J]. 山东大学学报(医学版), 2019,57(4): 52-58.
16 BROWNLOW J A, MILLER K E, GEHRMAN P R. Insomnia and cognitive performance[J]. Sleep Med Clin, 2020,15(1): 71-76. doi:10.1016/j.jsmc.2019.10.002
17 CAO X L, WANG S B, ZHONG B L, et al. The prevalence of insomnia in the general population in china: A meta-analysis[J]. PLoS One, 2017,12(2): e170772. doi:10.1371/journal.pone.0170772
18 李双艳, 张斌. 失眠障碍的研究现状与展望[J]. 实用医学杂志, 2024,40(6): 731-737.
19 CHAN N Y, CHAN J, LI S X, et al. Non-pharmacological approaches for management of insomnia[J]. Neurotherapeutics, 2021,18(1): 32-43. doi:10.1007/s13311-021-01029-2
20 WANG J, ZHAO H, SHI K, et al. Treatment of insomnia based on the mechanism of pathophysiology by acupuncture combined with herbal medicine: A review[J]. Medicine (Baltimore), 2023,102(11): e33213. doi:10.1097/md.0000000000033213
21 古翠方,翟明见,吕爱俊, 等. 超声引导下的星状神经节阻滞可改善老年肺癌患者胸腔镜术后早期睡眠:86例前瞻性随机对照试验[J].南方医科大学学报, 2022,42(12): 1807-1814.
22 LIU Y, ZHANG L, SUN Y, et al. Efficacy and safety of stellate ganglion block with different volumes of ropivacaine to improve sleep quality in patients with insomnia: A comparative study[J]. Eur Rev Med Pharmacol Sci, 2023,27(21): 10233-10239.
23 XU J, LIU Q, HUANG T, et al. Stellate ganglion block rectifies excessive daytime sleepiness: A case report[J]. J Int Med Res, 2022,50(8): 665787687. doi:10.1177/03000605221118681
24 WEBER F, DAN Y. Circuit-based interrogation of sleep control[J]. Nature, 2016,538(7623): 51-59. doi:10.1038/nature19773
25 EVANGELISTA E, RASSU A L, LOPEZ R, et al. Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia[J]. Sleep, 2022,45(1):zsab220. doi:10.1093/sleep/zsab220
26 BENDEROTH S, HORMANN H J, SCHIESSL C, et al. Reliability and validity of a 3-min psychomotor vigilance task in assessing sensitivity to sleep loss and alcohol: Fitness for duty in aviation and transportation[J]. Sleep, 2021,44(11):zsab151. doi:10.1093/sleep/zsab151
27 ZHANG X, HUANG X, YANG J. Efficacy of stellate ganglion block on postoperative sleep disorder: A systematic review[J]. Asian J Surg,2024,S1015-9584(24)02117-1. doi:10.1016/j.asjsur.2024.09.072
28 王烨, 郅娟, 邓晓明, 等. 右美托咪定经鼻喷雾治疗术后睡眠障碍的效果[J]. 临床麻醉学杂志, 2022,38(5): 477-481.
29 BOSCH O G, DORNBIERER D A, BAVATO F, et al. Dexmedetomidine in psychiatry: Repurposing of its fast-acting anxiolytic, analgesic and sleep modulating properties[J]. Pharmacopsychiatry, 2023,56(2): 44-50. doi:10.1055/a-1970-3453
30 张锦. 观察右美托咪定治疗顽固性失眠的效果[J]. 世界睡眠医学杂志, 2022,9(1): 36-38.
文章导航

/